Evidence-Based Medicine Guidelines
Oral antidiabetic drugs and GLP-1 analogues
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Oral Antidiabetic Drugs and GLP-1 Analogues." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/453594/all/Oral_antidiabetic_drugs_and_GLP_1_analogues.
Oral antidiabetic drugs and GLP-1 analogues. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/453594/all/Oral_antidiabetic_drugs_and_GLP_1_analogues. Accessed October 31, 2025.
Oral antidiabetic drugs and GLP-1 analogues. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/453594/all/Oral_antidiabetic_drugs_and_GLP_1_analogues
Oral Antidiabetic Drugs and GLP-1 Analogues [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 October 31]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/453594/all/Oral_antidiabetic_drugs_and_GLP_1_analogues.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Oral antidiabetic drugs and GLP-1 analogues
ID - 453594
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/453594/all/Oral_antidiabetic_drugs_and_GLP_1_analogues
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
